Cargando…
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
BACKGROUND: The Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported to have a high case-fatality rate. Currently, there is no specific therapy or vaccine with proven effectiveness for MERS-CoV infections. METHODS: A combination of ribavirin and interferon therapy was used for t...
Autores principales: | Al-Tawfiq, Jaffar A., Momattin, Hisham, Dib, Jean, Memish, Ziad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110882/ https://www.ncbi.nlm.nih.gov/pubmed/24406736 http://dx.doi.org/10.1016/j.ijid.2013.12.003 |
Ejemplares similares
-
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
por: Momattin, Hisham, et al.
Publicado: (2013) -
Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2014) -
A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
por: Momattin, Hisham, et al.
Publicado: (2019) -
Middle East respiratory syndrome coronavirus: epidemiology and disease
control measures
por: Al-Tawfiq, Jaffar A, et al.
Publicado: (2014) -
Middle East respiratory syndrome coronavirus infection control: The missing piece?
por: Memish, Ziad A., et al.
Publicado: (2014)